Passage BIO (PASG) EPS (Diluted) (2020 - 2026)
Passage BIO (PASG) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Passage BIO | 15.05 Mn | 15.05 Mn | - | -2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.58 |
| Mar 31, 2026 | -4.90 |
| Dec 31, 2025 | -8.55 |
| Sep 30, 2025 | -14.75 |
| Jun 30, 2025 | -15.63 |
| Mar 31, 2025 | -10.16 |
| Dec 31, 2024 | -77.52 |
| Sep 30, 2024 | -11.96 |
| Jun 30, 2024 | -19.61 |
| Mar 31, 2024 | -22.08 |
| Dec 31, 2023 | -80.04 |
| Sep 30, 2023 | -26.98 |
| Jun 30, 2023 | -16.39 |
| Mar 31, 2023 | -20.32 |
| Dec 31, 2022 | -76.28 |
| Sep 30, 2022 | -17.94 |
| Jun 30, 2022 | -32.97 |
| Mar 31, 2022 | -34.67 |
| Dec 31, 2021 | -70.09 |
| Sep 30, 2021 | -18.69 |